Abciximab
Diethylstilbestrol may decrease the anticoagulant activities of Abciximab.
Acenocoumarol
Diethylstilbestrol may decrease the anticoagulant activities of Acenocoumarol.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Diethylstilbestrol.
Advertisement
Acitretin
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Acitretin.
Adapalene
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Adapalene.
Alclometasone
The serum concentration of Alclometasone can be increased when it is combined with Diethylstilbestrol.
Advertisement
Aldosterone
The serum concentration of Aldosterone can be increased when it is combined with Diethylstilbestrol.
Alitretinoin
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Alitretinoin.
Alogliptin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Alogliptin.
Advertisement
alpha 1-Antitrypsin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Alpha-1-proteinase inhibitor.
Alpha 1-Proteinase Inhibitor, Human
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Alpha-1-proteinase inhibitor.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Diethylstilbestrol.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Diethylstilbestrol.
Amcinonide
The serum concentration of Amcinonide can be increased when it is combined with Diethylstilbestrol.
Aminophylline
The serum concentration of Aminophylline can be increased when it is combined with Diethylstilbestrol.
Amobarbital
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Amobarbital.
Amodiaquine
The serum concentration of Amodiaquine can be increased when it is combined with Diethylstilbestrol.
Amprenavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Amprenavir.
Anastrozole
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Diethylstilbestrol.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Diethylstilbestrol.
Ancrod
Diethylstilbestrol may decrease the anticoagulant activities of Ancrod.
Androstenedione
The serum concentration of Androstenedione can be increased when it is combined with Diethylstilbestrol.
Anthrax immune globulin, human
Diethylstilbestrol may increase the thrombogenic activities of Anthrax immune globulin human.
Antithrombin III
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Antithrombin III human.
Antithrombin III, Human
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Antithrombin III human.
Apalutamide
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Apalutamide.
Apixaban
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Apixaban.
Aprepitant
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Aprepitant.
Aprotinin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Aprotinin.
Ardeparin
Diethylstilbestrol may decrease the anticoagulant activities of Ardeparin.
Argatroban
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Argatroban.
Argatroban Anhydrous
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Argatroban.
Armodafinil
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Armodafinil.
Artemether
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Artemether.
Artesunate
The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Diethylstilbestrol resulting in a loss in efficacy.
Ascorbate
The serum concentration of Diethylstilbestrol can be increased when it is combined with Vitamin C.
Ascorbic Acid
The serum concentration of Diethylstilbestrol can be increased when it is combined with Vitamin C.
Asunaprevir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Asunaprevir.
Atazanavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Atazanavir.
Atorvastatin
The risk or severity of adverse effects can be increased when Diethylstilbestrol is combined with Atorvastatin.
Barbexaclone
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Barbexaclone.
Barbital
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Barbital.
Becaplermin
Diethylstilbestrol may decrease the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Diethylstilbestrol.
Benazepril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Benazepril.
Betamethasone
The serum concentration of Betamethasone can be increased when it is combined with Diethylstilbestrol.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Diethylstilbestrol.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Diethylstilbestrol.
Bexarotene
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Bexarotene.
Bivalirudin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Bivalirudin.
Boceprevir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Boceprevir.
Bosentan
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Diethylstilbestrol.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Diethylstilbestrol.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Diethylstilbestrol.
Budesonide
The serum concentration of Budesonide can be increased when it is combined with Diethylstilbestrol.
C1 esterase inhibitor (human)
Diethylstilbestrol may increase the thrombogenic activities of Human C1-esterase inhibitor.
C1 esterase inhibitor (recombinant)
Diethylstilbestrol may increase the thrombogenic activities of Conestat alfa.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Diethylstilbestrol.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Diethylstilbestrol.
Capromab Pendetide
Diethylstilbestrol may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Captopril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Captopril.
Carbamazepine
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Carbamazepine.
Celecoxib
Celecoxib may increase the thrombogenic activities of Diethylstilbestrol.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Diethylstilbestrol.
Certoparin
Diethylstilbestrol may decrease the anticoagulant activities of Certoparin.
Chenodeoxycholate
The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Diethylstilbestrol.
Chenodeoxycholic Acid
The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Diethylstilbestrol.
Cholesterol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Cholesterol.
Cholestyramine Resin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Cholestyramine.
Ciclesonide
The serum concentration of Ciclesonide can be increased when it is combined with Diethylstilbestrol.
Cilastatin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Cilastatin.
Cilazapril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Cilazapril.
Citric Acid
Diethylstilbestrol may decrease the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Diethylstilbestrol may decrease the anticoagulant activities of Citric Acid.
Clobazam
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Clobazam.
Clobetasol
The serum concentration of Clobetasol can be increased when it is combined with Diethylstilbestrol.
Clobetasol Propionate
The serum concentration of Clobetasol propionate can be increased when it is combined with Diethylstilbestrol.
Clobetasone
The serum concentration of Clobetasone can be increased when it is combined with Diethylstilbestrol.
Clocortolone
The serum concentration of Clocortolone can be increased when it is combined with Diethylstilbestrol.
Cobicistat
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Cobicistat.
Colesevelam
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Colesevelam.
Colestipol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Colestipol.
Cortisone Acetate
The serum concentration of Cortisone acetate can be increased when it is combined with Diethylstilbestrol.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Diethylstilbestrol.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Diethylstilbestrol.
Dabigatran Etexilate
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Dabigatran etexilate.
Dabrafenib
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Dabrafenib.
Dalteparin
Diethylstilbestrol may decrease the anticoagulant activities of Dalteparin.
Danaparoid
Diethylstilbestrol may decrease the anticoagulant activities of Danaparoid.
Darunavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Darunavir.
Deflazacort
The serum concentration of Deflazacort can be increased when it is combined with Diethylstilbestrol.
Desirudin
Diethylstilbestrol may decrease the anticoagulant activities of Desirudin.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Diethylstilbestrol.
Desonide
The serum concentration of Desonide can be increased when it is combined with Diethylstilbestrol.
Desoximetasone
The serum concentration of Desoximetasone can be increased when it is combined with Diethylstilbestrol.
Desoxycorticosterone acetate
The serum concentration of Desoxycorticosterone acetate can be increased when it is combined with Diethylstilbestrol.
Desoxycorticosterone Pivalate
The serum concentration of Desoxycorticosterone Pivalate can be increased when it is combined with Diethylstilbestrol.
Dexamethasone
The serum concentration of Dexamethasone can be increased when it is combined with Diethylstilbestrol.
Dextran
Diethylstilbestrol may decrease the anticoagulant activities of Dextran.
Dextran 40
Diethylstilbestrol may decrease the anticoagulant activities of Dextran 40.
Dextran 70
Diethylstilbestrol may decrease the anticoagulant activities of Dextran 70.
Dextran 75
Diethylstilbestrol may decrease the anticoagulant activities of Dextran 75.
Dicumarol
Diethylstilbestrol may decrease the anticoagulant activities of Dicoumarol.
Diflorasone
The serum concentration of Diflorasone can be increased when it is combined with Diethylstilbestrol.
Diflucortolone
The serum concentration of Difluocortolone can be increased when it is combined with Diethylstilbestrol.
Difluprednate
The serum concentration of Difluprednate can be increased when it is combined with Diethylstilbestrol.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Diethylstilbestrol.
Digoxin
Digoxin may decrease the cardiotoxic activities of Diethylstilbestrol.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Diethylstilbestrol.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Diethylstilbestrol.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Diethylstilbestrol.
Dyphylline
The serum concentration of Dyphylline can be increased when it is combined with Diethylstilbestrol.
Edetic Acid
Diethylstilbestrol may decrease the anticoagulant activities of Edetic Acid.
Edoxaban
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Edoxaban.
Elvitegravir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Elvitegravir.
Enalapril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Enalapril.
Enalaprilat
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Enalaprilat.
Enalaprilat Anhydrous
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Enalaprilat.
Enoxaparin
Diethylstilbestrol may decrease the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Diethylstilbestrol may decrease the anticoagulant activities of Enoxaparin.
Entacapone
The metabolism of Diethylstilbestrol can be decreased when combined with Entacapone.
Epigallocatechin Gallate
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Epigallocatechin Gallate.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Diethylstilbestrol.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Diethylstilbestrol.
Eslicarbazepine Acetate
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Eslicarbazepine acetate.
Estrone
The serum concentration of Estrone can be increased when it is combined with Diethylstilbestrol.
Ethylenediaminetetraacetate
Diethylstilbestrol may decrease the anticoagulant activities of Edetic Acid.
Etodolac
Etodolac may increase the thrombogenic activities of Diethylstilbestrol.
Etoricoxib
Etoricoxib may increase the thrombogenic activities of Diethylstilbestrol.
Exemestane
The therapeutic efficacy of Exemestane can be decreased when used in combination with Diethylstilbestrol.
Exenatide
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Exenatide.
Felbamate
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Felbamate.
Ferulic Acid
Diethylstilbestrol may decrease the anticoagulant activities of Ferulic acid.
Fibrinolysis Inhibitor
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Aprotinin.
Flibanserin
The serum concentration of Flibanserin can be increased when it is combined with Diethylstilbestrol.
Fludrocortisone
The serum concentration of Fludrocortisone can be increased when it is combined with Diethylstilbestrol.
Fluindione
Diethylstilbestrol may decrease the anticoagulant activities of Fluindione.
Flumethasone
The serum concentration of Flumethasone can be increased when it is combined with Diethylstilbestrol.
Flunisolide
The serum concentration of Flunisolide can be increased when it is combined with Diethylstilbestrol.
Flunisolide Anhydrous (obsolete)
The serum concentration of Flunisolide can be increased when it is combined with Diethylstilbestrol.
Fluocinolone Acetonide
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Diethylstilbestrol.
Fluocinonide
The serum concentration of Fluocinonide can be increased when it is combined with Diethylstilbestrol.
Fluocortolone
The serum concentration of Fluocortolone can be increased when it is combined with Diethylstilbestrol.
Fluorometholone
The serum concentration of Fluorometholone can be increased when it is combined with Diethylstilbestrol.
FLUPREDNIDENE
The serum concentration of Fluprednidene can be increased when it is combined with Diethylstilbestrol.
Fluprednisolone
The serum concentration of Fluprednisolone can be increased when it is combined with Diethylstilbestrol.
Flurandrenolide
The serum concentration of Flurandrenolide can be increased when it is combined with Diethylstilbestrol.
Fluticasone Furoate
The serum concentration of Fluticasone furoate can be increased when it is combined with Diethylstilbestrol.
Fluticasone propionate
The serum concentration of Fluticasone propionate can be increased when it is combined with Diethylstilbestrol.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Diethylstilbestrol.
Fondaparinux
Diethylstilbestrol may decrease the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Diethylstilbestrol may decrease the anticoagulant activities of Fondaparinux sodium.
Formestane
The serum concentration of Formestane can be increased when it is combined with Diethylstilbestrol.
Fosamprenavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Fosaprepitant.
Fosinopril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Fosinopril.
Fosphenytoin
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Fosphenytoin.
Griseofulvin
The metabolism of Diethylstilbestrol can be increased when combined with Griseofulvin.
Griseofulvin microsize
The metabolism of Diethylstilbestrol can be increased when combined with Griseofulvin.
Halcinonide
The serum concentration of Halcinonide can be increased when it is combined with Diethylstilbestrol.
Halobetasol
The serum concentration of Ulobetasol can be increased when it is combined with Diethylstilbestrol.
Heparin
Diethylstilbestrol may decrease the anticoagulant activities of Heparin.
Hexobarbital
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Hexobarbital.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Diethylstilbestrol.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Diethylstilbestrol.
Hydrocortisone
The serum concentration of Hydrocortisone can be increased when it is combined with Diethylstilbestrol.
Hypoxis hemerocallidea root extract
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Diethylstilbestrol.
Imidapril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Imidapril.
Indinavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Indinavir.
Isavuconazole
The serum concentration of Diethylstilbestrol can be increased when it is combined with Isavuconazole.
Isoflurophate
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Isoflurophate.
Isotretinoin
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Isotretinoin.
Ixazomib
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Ixazomib.
Lamotrigine
The serum concentration of Lamotrigine can be decreased when it is combined with Diethylstilbestrol.
Lenalidomide
Diethylstilbestrol may increase the thrombogenic activities of Lenalidomide.
Lepirudin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Lepirudin.
Levothyroxine
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Diethylstilbestrol.
Linagliptin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Linagliptin.
Liothyronine
The therapeutic efficacy of Liothyronine can be decreased when used in combination with Diethylstilbestrol.
Lisinopril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Lisinopril.
Lisinopril Anhydrous
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Lisinopril.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Diethylstilbestrol.
Lopinavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Lopinavir.
Loteprednol
The serum concentration of Loteprednol can be increased when it is combined with Diethylstilbestrol.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Diethylstilbestrol.
Lumacaftor
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Lumacaftor.
Medrysone
The serum concentration of Medrysone can be increased when it is combined with Diethylstilbestrol.
Mephobarbital
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Methylphenobarbital.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Diethylstilbestrol.
Methohexital
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Methohexital.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Diethylstilbestrol.
Methylprednisolone
The serum concentration of Methylprednisolone can be increased when it is combined with Diethylstilbestrol.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Diethylstilbestrol.
Metreleptin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Metreleptin.
Mifepristone
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Mifepristone.
Modafinil
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Modafinil.
Moexipril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Moexipril.
Mometasone
The serum concentration of Mometasone can be increased when it is combined with Diethylstilbestrol.
MYCOPHENOLATE
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Mycophenolic acid.
Mycophenolic Acid
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Mycophenolic acid.
Nabumetone
Nabumetone may increase the thrombogenic activities of Diethylstilbestrol.
Nadroparin
Diethylstilbestrol may decrease the anticoagulant activities of Nadroparin.
Nafcillin
The metabolism of Diethylstilbestrol can be increased when combined with Nafcillin.
Nelfinavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Nelfinavir.
Nevirapine
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Diethylstilbestrol.
O-PHENANTHROLINE
The serum concentration of Diethylstilbestrol can be decreased when it is combined with 1,10-Phenanthroline.
Ospemifene
The risk or severity of adverse effects can be increased when Diethylstilbestrol is combined with Ospemifene.
Ouabain
Ouabain may decrease the cardiotoxic activities of Diethylstilbestrol.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Diethylstilbestrol.
Oxcarbazepine
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Oxcarbazepine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Diethylstilbestrol.
Paramethasone
The serum concentration of Paramethasone can be increased when it is combined with Diethylstilbestrol.
Parecoxib
Parecoxib may increase the thrombogenic activities of Diethylstilbestrol.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Diethylstilbestrol.
Pentaerythritol Tetranitrate
Diethylstilbestrol may decrease the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentobarbital
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Pentobarbital.
Pentosan Polysulfate
Diethylstilbestrol may decrease the anticoagulant activities of Pentosan Polysulfate.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Diethylstilbestrol.
Perindopril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Perindopril.
Phenindione
Diethylstilbestrol may decrease the anticoagulant activities of Phenindione.
Phenobarbital
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Phenobarbital.
Phenprocoumon
Diethylstilbestrol may decrease the anticoagulant activities of Phenprocoumon.
Phenytoin
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Phenytoin.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Diethylstilbestrol.
Prasterone
The risk or severity of adverse effects can be increased when Prasterone is combined with Diethylstilbestrol.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Diethylstilbestrol.
Prednicarbate
The serum concentration of Prednicarbate can be increased when it is combined with Diethylstilbestrol.
Prednisolone
The serum concentration of Prednisolone can be increased when it is combined with Diethylstilbestrol.
Prednisone
The serum concentration of Prednisone can be increased when it is combined with Diethylstilbestrol.
Pregnenolone
The serum concentration of Pregnenolone can be increased when it is combined with Diethylstilbestrol.
Primidone
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Primidone.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Diethylstilbestrol.
protein C, human
Diethylstilbestrol may decrease the anticoagulant activities of Protein C.
protein S, human
Diethylstilbestrol may decrease the anticoagulant activities of Protein S human.
Protocatechualdehyde
Diethylstilbestrol may decrease the anticoagulant activities of Protocatechualdehyde.
Quinapril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Quinapril.
Racecadotril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Racecadotril.
Ramipril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Ramipril.
Ranolazine
The serum concentration of Diethylstilbestrol can be increased when it is combined with Ranolazine.
Reviparin
Diethylstilbestrol may decrease the anticoagulant activities of Reviparin.
Reviparin sodium
Diethylstilbestrol may decrease the anticoagulant activities of Reviparin.
Rifabutin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Rifapentine.
Rifaximin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Rifaximin.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Diethylstilbestrol.
Rimexolone
The serum concentration of Rimexolone can be increased when it is combined with Diethylstilbestrol.
Ritonavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Ritonavir.
Rivaroxaban
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Rivaroxaban.
Rofecoxib
Rofecoxib may increase the thrombogenic activities of Diethylstilbestrol.
Ropinirole
The serum concentration of Ropinirole can be increased when it is combined with Diethylstilbestrol.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Diethylstilbestrol.
Saquinavir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Saquinavir.
Saxagliptin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Saxagliptin.
Saxagliptin Anhydrous
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Saxagliptin.
Secobarbital
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Secobarbital.
Selegiline
The serum concentration of Selegiline can be increased when it is combined with Diethylstilbestrol.
Simeprevir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Diethylstilbestrol.
Sitagliptin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Sitagliptin.
Sitagliptin Phosphate
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Sitagliptin.
Somatropin
The therapeutic efficacy of Somatotropin can be decreased when used in combination with Diethylstilbestrol.
Spirapril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Spirapril.
ST. JOHN'S WORT EXTRACT
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with St. John's Wort.
Telaprevir
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Telaprevir.
Testosterone Propionate
The metabolism of Diethylstilbestrol can be decreased when combined with Testosterone propionate.
Thalidomide
Diethylstilbestrol may increase the thrombogenic activities of Thalidomide.
Theophylline
The serum concentration of Theophylline can be increased when it is combined with Diethylstilbestrol.
Theophylline anhydrous
The serum concentration of Theophylline can be increased when it is combined with Diethylstilbestrol.
Thiamylal
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Thiamylal.
Thiopental
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Thiopental.
Thiopental Sodium
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Thiopental.
Thyroid, Porcine
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Diethylstilbestrol.
Tipranavir
Diethylstilbestrol may increase the dermatologic adverse activities of Tipranavir.
Tixocortol
The serum concentration of Tixocortol can be increased when it is combined with Diethylstilbestrol.
Tolcapone
The metabolism of Diethylstilbestrol can be decreased when combined with Tolcapone.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Diethylstilbestrol.
Topiramate
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Diethylstilbestrol.
Trandolapril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Trandolapril.
Tranexamic Acid
Diethylstilbestrol may increase the thrombogenic activities of Tranexamic Acid.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Diethylstilbestrol.
Tretinoin
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Tretinoin.
Triamcinolone
The serum concentration of Triamcinolone can be increased when it is combined with Diethylstilbestrol.
Troxerutin
Diethylstilbestrol may decrease the anticoagulant activities of Troxerutin.
Ursodeoxycholate
The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Diethylstilbestrol.
Ursodiol
The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Diethylstilbestrol.
Valdecoxib
Valdecoxib may increase the thrombogenic activities of Diethylstilbestrol.
Vemurafenib
The serum concentration of Diethylstilbestrol can be increased when it is combined with Vemurafenib.
Vildagliptin
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Vildagliptin.
Voriconazole
The metabolism of Diethylstilbestrol can be decreased when combined with Voriconazole.
Warfarin
Diethylstilbestrol may decrease the anticoagulant activities of Warfarin.
Zofenopril
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Zofenopril.
